Purpose To update the 2006 American Society of Clinical Oncology guideline on the use of
hematopoietic colony-stimulating factors (CSFs). Methods The American Society of Clinical …

Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

Background Long-term hormone therapy has been the standard of care for advanced
prostate cancer since the 1940s. STAMPEDE is a randomised controlled trial using a …

Despite major advances in prevention and treatment, FN remains one of the most frequent
and serious complications of cancer chemotherapy (ChT). It is a major cause of morbidity …

Colorectal cancer (CRC) is the most common tumour type in both sexes combined in
Western countries. Although screening programmes including the implementation of faecal …

Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …

Neutropenia with fever (febrile neutropenia [FN]) is a serious consequence of
myelosuppressive chemotherapy that usually results in hospitalization and the need for …

EUSOMA (The European Society of Breast Cancer Specialists) is committed to writing
recommendations on different topics of breast cancer care which can be easily adopted and …

abstract Bloodstream infections (BSI) are among the most frequent complications in
neutropenic cancer patients and, if caused by Gram-negative rods, are associated with high …

Background Present first-line therapy for diffuse large B-cell lymphoma, a subtype of non-
Hodgkin lymphoma, is rituximab, cyclophosphamide, doxorubicin, vincristine, and …